These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 183158

  • 1. [Immunosuppressive therapy of myasthenia gravis].
    Lechner H, Ott E, Aranibar A.
    Nervenarzt; 1976 Jun; 47(6):353-6. PubMed ID: 183158
    [No Abstract] [Full Text] [Related]

  • 2. [Current therapeutic aspects of myasthenia gravis].
    Avilés Mejias S, Ledro Molina D, Garrido Peralta M.
    Rev Clin Esp; 1981 Oct 31; 163(2):139-44. PubMed ID: 6276943
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Therapies of myasthenia gravis (author's transl)].
    de Crousaz G.
    Schweiz Rundsch Med Prax; 1978 Jan 24; 67(4):113-7. PubMed ID: 202937
    [No Abstract] [Full Text] [Related]

  • 5. [Therapy of myasthenia gravis].
    Jerusalem F.
    Dtsch Med Wochenschr; 1977 Aug 12; 102(32):1160-3. PubMed ID: 196820
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of myasthenia].
    Goulon M, Estournet B, Gajdos P.
    Rev Prat; 1979 Jun 21; 29(35):2789-99. PubMed ID: 493836
    [No Abstract] [Full Text] [Related]

  • 7. [Immunosuppressive treatment in neurological disorders].
    Aarli JA.
    Tidsskr Nor Laegeforen; 1973 Jun 30; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of myasthenia gravis--the clinical course and description of intractable cases].
    Mozai T.
    Nihon Rinsho; 1971 Nov 30; 29(11):2525-32. PubMed ID: 4334788
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Myasthenia gravis].
    Gajdos P.
    Rev Prat; 2002 Jan 01; 52(1):71-7. PubMed ID: 11852770
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of myasthenia gravis].
    Gajdos P.
    Presse Med; 1989 Oct 28; 18(35):1732-4. PubMed ID: 2531386
    [No Abstract] [Full Text] [Related]

  • 13. Myasthenia gravis (second of two parts).
    Drachman DB.
    N Engl J Med; 1978 Jan 26; 298(4):186-93. PubMed ID: 339085
    [No Abstract] [Full Text] [Related]

  • 14. [Immunological and therapeutic aspects of myasthenia gravis (author's transl)].
    Ghezzi M, Taiuti R, Marconi G.
    Riv Patol Nerv Ment; 1981 Jan 26; 102(1):12-28. PubMed ID: 6285444
    [Abstract] [Full Text] [Related]

  • 15. The treatment of patients with myasthenia gravis.
    Sanders DB, Scoppetta C.
    Neurol Clin; 1994 May 26; 12(2):343-68. PubMed ID: 8041346
    [Abstract] [Full Text] [Related]

  • 16. [Myasthenia gravis. Indications, aims and methods of intensive therapy].
    Braschi A, Scherini A, Carbonera D, Mapelli A, Bellinzona G, Bobbio Pallavicini F, Dionigi R, Gasperi A.
    Minerva Anestesiol; 1979 Nov 26; 45(11):871-81. PubMed ID: 548812
    [Abstract] [Full Text] [Related]

  • 17. [Thymus and myasthenia].
    de Crousaz G, Zoupanos G.
    Rev Med Suisse Romande; 1973 Feb 26; 93(2):143-58. PubMed ID: 4704793
    [No Abstract] [Full Text] [Related]

  • 18. [Therapy of myasthenia gravis].
    Henze T.
    Dtsch Med Wochenschr; 1986 Mar 28; 111(13):507-9. PubMed ID: 3956394
    [No Abstract] [Full Text] [Related]

  • 19. [The therapy of myasthenia gravis pseudoparalytica].
    Baumgartner RW, Waespe W.
    Dtsch Med Wochenschr; 1991 Jan 25; 116(4):148-54. PubMed ID: 1988277
    [No Abstract] [Full Text] [Related]

  • 20. Biology of myasthenia gravis.
    Lindstrom J, Dau P.
    Annu Rev Pharmacol Toxicol; 1980 Jan 25; 20():337-62. PubMed ID: 6992700
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.